OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
9.81
-0.21 (-2.10%)
Jul 22, 2024, 10:09 AM EDT - Market open
OptimizeRx Employees
As of December 31, 2023, OptimizeRx had 136 total employees, including 135 full-time and 1 part-time employees. The number of employees increased by 26 or 23.64% compared to the previous year.
Employees
136
Change (1Y)
26
Growth (1Y)
23.64%
Revenue / Employee
$575,063
Profits / Employee
-$132,847
Market Cap
179.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 1,024 |
Coherus BioSciences | 306 |
Seres Therapeutics | 233 |
908 Devices | 230 |
Inhibrx | 172 |
Biomea Fusion | 103 |
XBiotech | 82 |
Candel Therapeutics | 42 |
OPRX News
- 7 days ago - OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients - GlobeNewsWire
- 4 weeks ago - New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations - GlobeNewsWire
- 2 months ago - OptimizeRx Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 3 months ago - OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report - GlobeNewsWire
- 3 months ago - OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row - GlobeNewsWire